June 30 2010, Chemgenix had 12.8 million in the bank thanks to a CR with ABN Ambro Morgans clients and existing shareholders at the end of 2008.
2010, shares drop over 65% because of FDA delays, having reached $1.00.
Dr Greg Collier 70 cent options are out of the money and expire. February 2011, shareholders approve 4.6 million new options at 47.5 cents.
March 2011 Cephalon announce a 225 million takeover at 70 cents a share.
Dr Collier pockets $1.5 million. ( which I am sure he deserved).
Nonetheless, not a lot of similarities other than Brett Heading being chairman, Dr James Campbell COO, Dr Greg Collier CEO. Certainly no last minute dash for options before this AGM.
IVX Price at posting:
1.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)